|
Takeda Pharmaceutical Co. Ltd.
(NYSE: TAK)
|
9:00 PM UTC, 12/12/25 | |||
|---|---|---|---|---|
| Last: $14.33 | Change: -0.06 | %Change: -0.42% | Volume: 2,123,444 | |
05:37 AM EST, 01/30/2025 (MT Newswires) -- Takeda Pharmaceutical (TAK) said Thursday it has appointed Julie Kim as chief executive.
Kim, who is the president of the company's US business unit, will succeed Christophe Weber when he retires in June 2026.
After retirement, Weber will not hold a seat on the board, the company said.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.